Fig. 6.
Different effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction compared with placebo or active compounds in some clinical trials [39–47]. AMI acute myocardial infarction, CCB calcium channel blocker, CI confidence interval, HR hazard ratio